Lanean...
Atorvastatin solid dispersion for bioavailability enhancement
Atorvastatin calcium is a lipid-lowering agent. It has approximately 15% of bioavailability, remaining amount of drug showed adverse effect which is undesirable for patients. The objective of the study was to enhance the solubility and a dissolution profile of the atorvastatin (AT) calcium. Solid di...
Gorde:
| Argitaratua izan da: | J Adv Pharm Technol Res |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Medknow Publications & Media Pvt Ltd
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4759982/ https://ncbi.nlm.nih.gov/pubmed/26955607 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2231-4040.169873 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|